Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer's disease

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 12, Issue 2, 2000, Pages 209-218

  Mega, Michael S ^a   Dinov, Ivo D ^b   Lee, Linda ^b   O'Connor, Susan M ^b   Masterman, Donna M ^b   Wilen, Barry ^b   Mishkin, Fred ^b   Toga, Arthur W ^b   Cummings, Jeffrey L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADOLESCENT; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR; BRAIN PERFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; EUPHORIA; FEMALE; HUMAN; IRRITABILITY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0034028606     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.12.2.209     Document Type: Article

References (31)

1. Cummings JL, Kaufer D: Neuropsychiatric aspects of Alzheimer's disease: the cholinergic hypothesis revisited. Neurology 1996; 47:876-883
2. Kaufer DI, Cummings JL, Christine D: Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study. J Geriatr Psychiatry Neurol 1996;9:1-6
3. Cummings JL, Cyrus PA, Ruzicka BB, et al: The efficacy of metrifonate in improving the behavioral disturbances of Alzheimer's disease. Neurology 1998;50:A251
4. Mega MS, Masterman DM, O'Connor SM, et al: The spectrum of behavioral responses with cholinesterase inhibitor therapy in Alzheimer's disease. Arch Neurol 1999; 1388-1393
5. Cummings JL, Gorman DG, Shapira J: Physostigmine ameliorates the delusions of Alzheimer's disease. Biol Psychiatry 1993; 33:536-541
6. Sunderland T, Tariot PN, Newhouse PA: Differential responsivity of mood, behavior, and cognition to cholinergic agents in elderly neuropsychiatric populations. Brain Res Brain Res Rev 1988; 13:371-389
7. Starkstein SE, Vazquez S, Petracca G, et al: A SPECT study of delusions in Alzheimer's disease. Neurology 1994; 44:2055-2059
8. Sultzer DL, Mahler ME, Mandelkern MA, et al: The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1995; 7:476-484
9. Mentis MJ, Weinstein EA, Horwitz B, et al: Abnormal glucose metabolism in the delusional misidentification syndromes: a positron tomography study in Alzheimer's disease. Biol Psychiatry 1995; 38:438-449
10. Mega MS, Lee L, Dinov ID, et al: Cerebral correlates of psychotic symptoms in Alzheimer's disease. J Neurol Neurosurg Psychiatry (in press)
11. Davis KL, Hollander E, Davidson M, et al: Induction of depression with oxotremorine in patients with Alzheimer's disease. Am J Psychiatry 1987; 144:468-471
12. Whitehouse P: Intraventricular bethanechol in Alzheimer's disease: a continuing controversy. Neurology 1988; 38:307-308
13. Newhouse PA, Sunderland T, Tariot PN, et al: Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacol (Berl) 1988; 95:171-175
14. Cummings JL, Mega MS, Gray K, et al: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314
15. Morris JC, Cyrus PA, Orazem J, et al: Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease. Neurology 1998; 50:1222-1230
16. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group, Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
17. Cummings JL, Benson DF, LoVerme S: Reversible dementia: illustrative cases, definition, and review. JAMA 1980; 243:2434-2439
18. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the mental state of patients for the clinician. J Psychiatry Res 1975; 12:189-198
19. Rogers SL, Farlow MR, Doody RS, et al: A 24-week, double-blind, placebo-controlled trial of Aricept® in patients with Alzheimer's disease. Neurology 1998; 50:136-145
20. Efron B, Tibshirani R: Statistical data analysis in the computer age. Science 1991; 253:390-395
21. Woods RP, Grafton ST, Watson JDG, et al: Automated image registration, II: intersubject validation of linear and nonlinear models. J Comput Assist Tomogr 1998; 22:153-165
22. Evans AC, Collins DL, Holmes CJ: Automated 3D regional MRI segmentation and statistical probabilistic anatomical maps, in Human Brain Mapping: The Methods, edited by Toga AW, Mazziotta JC. New York, Academic Press, 1996, pp 123-130
23. Dinov ID, Mega MS, Thompson PM, et al: Analyzing functional brain images in a probabilistic atlas: a validation of sub-volume thresholding. J Comput Assist Tomogr 2000; 24:128-138
24. Price JL, Davis PB, Morris JC, et al: The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 1991; 12:295-312
25. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991; 82:239-259
26. Talairach J, Tournoux P: Principe et technique des etudes anatomiques [Principles and techniques of anatomical studies], in Co-Planar Stereotaxic Atlas of the Human Brain, 3-Dimensional Proportional System: An Approach to Cerebral Imaging, edited by Rayport M. New York, Thieme Medical, 1988
27. Mega MS, Cummings JL, Salloway S, et al: The limbic system: an anatomic, phylogenetic, and clinical perspective. J Neuropsychiatry Clin Neurosci 1997; 9:315-330
28. Logue V, Durward M, Pratt RTC, et al: The quality of survival after an anterior cerebral aneurysm. Br J Psychiatry 1968; 114:137-160
29. Hunter R, Blackwood W, Bull J: Three cases of frontal meningiomas presenting psychiatrically. British Medical Journal 1968; 3:9-16
30. Bogousslavsky J, Regli F: Anterior cerebral artery territory infarction in the Lausanne stroke registry. Arch Neurol 1990; 47:144-150
31. Hunter R, Wyper DJ, Patterson J, et al: Cerebral pharmacodynamics of physostigmine in Alzheimer's disease investigated using single-photon computed tomography. Br J Psychiatry 1991; 158:351-357